These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35502765)

  • 1. Methylation site
    Yang Z; Chen W; Zhu H; Zhang L; Zhou K; Tang H; Sun R; Huang Y; Xie H; Zheng S; Jia C
    Future Oncol; 2022 Jun; 18(19):2401-2413. PubMed ID: 35502765
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation.
    Yang Z; Zhu H; Zhang L; Wei Q; Zhou L; Xu X; Song P; Liu J; Xie H; Zheng S
    Mol Biol Rep; 2020 Mar; 47(3):1773-1782. PubMed ID: 32006198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma.
    Long J; Chen P; Lin J; Bai Y; Yang X; Bian J; Lin Y; Wang D; Yang X; Zheng Y; Sang X; Zhao H
    Theranostics; 2019; 9(24):7251-7267. PubMed ID: 31695766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
    Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
    Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
    Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
    Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
    Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
    Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
    Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
    Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.
    Umeda S; Kanda M; Sugimoto H; Tanaka H; Hayashi M; Yamada S; Fujii T; Takami H; Niwa Y; Iwata N; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y
    BMC Cancer; 2017 Sep; 17(1):610. PubMed ID: 28863781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
    He D; Liao S; Cai L; Huang W; Xie X; You M
    BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes associated with recurrence of hepatocellular carcinoma: integrated analysis by gene expression and methylation profiling.
    Yang JD; Seol SY; Leem SH; Kim YH; Sun Z; Lee JS; Thorgeirsson SS; Chu IS; Roberts LR; Kang KJ
    J Korean Med Sci; 2011 Nov; 26(11):1428-38. PubMed ID: 22065898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating cell-free DNA of methylated insulin-like growth factor-binding protein 7 predicts a poor prognosis in hepatitis B virus-associated hepatocellular carcinoma after hepatectomy.
    Li F; Qiao CY; Gao S; Fan YC; Chen LY; Wang K
    Free Radic Res; 2018 Apr; 52(4):455-464. PubMed ID: 29463155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.
    Chen D; Liu S; Chen S; Wang Z; Wu Z; Ma K; Fan J; Peng Z
    Int J Clin Oncol; 2016 Dec; 21(6):1111-1119. PubMed ID: 27368337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas.
    Cui C; Lu Z; Yang L; Gao Y; Liu W; Gu L; Yang C; Wilson J; Zhang Z; Xing B; Deng D; Sun ZS
    Mol Carcinog; 2016 Jul; 55(7):1163-74. PubMed ID: 26138747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.